Bronchial Hyperresponsiveness in Pediatric Non‐Cystic Fibrosis Bronchiectasis

Lisa Gerbeau Armelle Finet M. Bertrand Emmanuelle Bosdure L. Papazian Kenza Tahiri Mélisande Baravalle J. Mazenq Jean-Christophe Dubus

Sep 2026 · Pediatric Pulmonology · Vol 61 · 0 citations · 26 references

Medicine

Abstract

The prevalence and significance of bronchial hyperresponsiveness (BHR) in patients with non‐cystic fibrosis (CF) bronchiectasis remain unclear. The objective is to determine the prevalence of BHR, defined as a post‐bronchodilator forced expiratory volume in 1 s (FEV1) improvement > 10%, in children with non‐CF bronchiectasis and to assess its association with clinical, functional, and radiological characteristics.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Oct 2026

Efficacy of Inhaled Colistin versus Oral Azithromycin in Preventing Exacerbation among Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Study

Recurrent exacerbation of non-cystic fibrosis bronchiectasis should be treated with long-term antibiotics, especially those with chronic Gram-negative bacterial colonization.

S. Hiremath, Harsha Hanji, Vinayakumar Jogondra et al. · International Journal of Dru... · 0 citations

Editorial Open access Oct 2026

Evaluating the Efficacy of Brensocatib in Non-cystic Fibrosis Bronchiectasis

Bronchiectasis is a widely recognised chronic respiratory illness classified in severity by frequency of exacerbations within the past year, percent predicted forced expiratory volume in 1 second (%FEV1), previous hospital admissions and radiological severity, among other factors. The physiological process is understoo...

Alan Mathew, Hannah Anwar · Cureus · 0 citations

Oct 2026

Longitudinal Characterization of the Microbiological Status in Primary Ciliary Dyskinesia: An Italian Multicentre Study

Prevalence and longitudinal changes of respiratory microbiological profile in children and young adults with PCD, and their association with clinical, functional, and radiological features are evaluated.

V. Ferraro, Valentina Tonazzo, A. Pandolfo et al. · Pediatric Pulmonology · 0 citations

Review Sep 2026

[Bronchiectasis in children: An underdiagnosed disease with accessible screening and etiological assessment].

Long considered as a rare and neglected disease, non-cystic fibrosis bronchiectasis in children is now recognized as an emerging cause of chronic respiratory morbidity worldwide. Its incidence is strikingly variable, ranging from 0.2-2.3 per 100,000 children annually in high-income countries to more than 700 per 100,00...

I. Mansouri, D. Benchaji, A. Errami et al. · Revue des maladies respirato... · 0 citations

Case report Oct 2026

Unravelling A Rare Diagnosis: Pulmonary Alveolar Proteinosis.

Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by abnormal accumulation of surfactant within the alveoli, leading to impaired gas exchange and progressive respiratory symptoms. We report a 40-year-old stone grinder presenting with chronic cough, dyspnea, weight loss and hypoxemia. High-resolution...

Rohan Govil, Arpita Mathur, Sunil Kumar Agarwal et al. · Cytopathology · 0 citations

Sep 2026

Utility of the expiratory disproportion index in early detection of idiopathic subglottic stenosis masked by asthma.

Idiopathic subglottic stenosis (iSGS) is a rare fibrotic condition causing fixed extrathoracic airway obstruction, predominantly affecting postmenopausal women. The expiratory disproportion index (EDI), calculated as forced expiratory volume in one second (FEV1) (mL)/peak expiratory flow (PEF) (L/min), can help differe...

S. Sridhara, Anirudh Burli · Proceedings · 0 citations